🔎 Trials Near Me

Akèy › Fibroz Pulmonè Idyopatik › Alabama

Etid klinik pou Fibroz Pulmonè Idyopatik nan Alabama

9 etid pou Fibroz Pulmonè Idyopatik ap chèche patisipan nan sit nan Alabama.

Vil nan Alabama

Tèks ofisyèl etid la (Anglè)

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06951217

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  • Research Site, Birmingham
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07652658

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UAB, Psychiatry and Behavioral Neurology, Birmingham
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • UAB Lung Health Center, Birmingham
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  • The University of Alabama at Birmingham /ID# 277613, Birmingham
  • Sec Clinical Research - East - Dothan - Graceland /ID# 278328, Dothan
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07230288

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

  • The University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 40 a 85 · Tout sèks · Mizajou Aug 12, 2026 · NCT04362644

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Alabama - Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  • WISPer Site in Birmingham, AL, Birmingham
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06967805

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.